Definitive Contract 75N95018C00041
Award Date
9/21/18
Potential Completion Date
9/28/23
Potential Value
$1.4M
Federal Agency
National Institute on Drug Abuse
Awardee
Sri International
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
West Menlo Park, CA 94025, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with a ceiling value of $1,927,163.66, was issued by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services. The contract was awarded to SRI International, a non-profit research and development organization, and is part of NIDA's Pharmacology and Toxicology for Neurotherapeutics Program (PTNP). The contract, which is a Delivery Order under the PTNP Indefinite Delivery Vehicle (IDV), is for IND-enabling studies....
This is a Cost Plus Fixed Fee definitive contract awarded by the National Institute on Drug Abuse (NIDA), a component of the Department of Health and Human Services, to SRI International, a non-profit research institute. The $3,698,818.25 contract is for non-clinical absorption, distribution, metabolism, and excretion (ADME) studies, with a period of performance from September 19, 2016 to September 18, 2021. This award does not have a small business set-aside. SRI International, as the prime...
This is a federal contract award from the National Institute on Drug Abuse (NIDA), a civilian agency, to SRI International, a non-profit research and development organization. The contract is an administrative task order under the Pharmacology and Toxicology for Neurotherapeutics Program (PTNP) indefinite delivery vehicle (IDV). The total ceiling value of this award is $106,072.00, and the period of performance is from September 13, 2015 to September 12, 2016. The contract is a...
This is a cost-plus-fixed-fee delivery order task order awarded by the Department of Health and Human Services' National Institute on Drug Abuse (NIDA) to nonprofit research institute SRI International. The contract, valued at $479,933.60, is for toxicological evaluations of potential medications over a period of performance from September 7, 2018 to September 6, 2023. SRI International has extensive experience providing research, engineering, and technical services to federal agencies such as...
This federal contract award was issued by the National Institute on Drug Abuse (NIDA), a civilian agency, to Sri International, a non-profit research and development institute. The contract, valued at $175,508.78, is for non-rodent pharmacokinetic assessment services under NIDA's Pharmacology and Toxicology for Neurotherapeutics Program (PTNP). The contract is a delivery order under the PTNP indefinite delivery vehicle (IDV) and has a cost-plus-fixed-fee pricing type. The contract does not...
This is a definitive, cost-plus-fixed-fee contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency under the U.S. Department of Health and Human Services. The contract, valued at $11,883,375.62, was awarded on December 15, 2002 to Sri International, a non-profit research and development institute, for the purpose of de-obligating FY2006 funds. The contract has a period of performance through December 31, 2009 and is being performed in West Menlo Park, CA. Sri...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a Cost Plus Fixed Fee delivery order contract to SRI International, a non-profit research and development institute. The $1,256,044.00 contract is for GLP (Good Laboratory Practice) interaction safety studies in rats and dogs, under an Indefinite Delivery Indefinite Quantity (IDIQ) contract vehicle. The contract is not set aside for any specific business type. SRI International...
This is a cost-plus-fixed-fee delivery order contract awarded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), to SRI International, a non-profit research and development institute. The contract, worth $138,512.00, is for acute toxicology testing of a radiotracer for cyclooxygenase-1 (COX-1) during the performance period of June 30, 2015 to June 29, 2016. This contract is not set aside for any particular business category. SRI International has a...
This task order was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse to SRI International, a non-profit research institute, for an expanded study on acute toxicology for a radiotracer under the NIMH Toxicological Evaluation of Novel Ligands Program. The task order has a firm fixed price of $203,534 and a completion date of September 30, 2021. It is not designated as a set-aside contract. SRI International has...
This is a $1,773,704.00 Cost Plus Fixed Fee contract awarded by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services, to Sri International, a non-profit research and development institute. The contract is for a GLP (Good Laboratory Practice) Single Dose Toxicity Study in Dogs, to support the NIDA's Toxicological Evaluations of Potential Medications program. The contract period of performance is from September 13, 2024 to September 12, 2025....